User talk:Yufeifeii

Problems with upload of File:Compound.PNG

Thanks for uploading File:Compound.PNG. You don't seem to have said where the image came from, who created it, or what the copyright status is. We require this information to verify that the image is legally usable on Wikipedia, and because most image licenses require giving credit to the image's creator.

To add this information, click on this link, then click the "Edit" tab at the top of the page and add the information to the image's description. If you need help, post your question on Wikipedia:Media copyright questions.

For more information on using images, see the following pages:

Thank you for your cooperation. --ImageTaggingBot (talk) 08:30, 7 July 2023 (UTC)[reply]

Your submission at Articles for creation: Pimicotinib (August 23)

Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by DMacks was:

This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:

in-depth (not just passing mentions about the subject)
reliable
secondary
independent of the subject

Make sure you add references that meet these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.

The comment the reviewer left was:

Most refs are press-release or other publications by the company developing this chemical. WP:MEDRS is the relevant standard. The article itself sounds more like a press release than summarizing main ideas for encyclopedia readers, which is not an uncommon problem for writing by editors with COI (disclosed on their userpage but not here at article).

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.

If you would like to continue working on the submission, go to Draft:Pimicotinib and click on the "Edit" tab at the top of the window.
If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

DMacks (talk) 09:07, 23 August 2023 (UTC)[reply]

Hello, Yufeifeii! Having an article draft declined at Articles for Creation can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! DMacks (talk) 09:07, 23 August 2023 (UTC)[reply]

Your submission at Articles for creation: Pimicotinib (November 4)

Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reasons left by Oltrepier were:

This submission provides insufficient context for those unfamiliar with the subject matter. Please see the guide to writing better articles for information on how to better format your submission.

This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:

in-depth (not just passing mentions about the subject)
reliable
secondary
independent of the subject

Make sure you add references that meet these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.

The comment the reviewer left was:

It looks better than the last review, but I think there are still some issues with WP:NPOV, the lack of secondary sources and, most importantly, the lack of context overall...

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.

If you would like to continue working on the submission, go to Draft:Pimicotinib and click on the "Edit" tab at the top of the window.
If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

Oltrepier (talk) 21:25, 4 November 2023 (UTC)[reply]

AfC notification: Draft:Pimicotinib has a new comment

I've left a comment on your Articles for Creation submission, which can be viewed at Draft:Pimicotinib. Thanks! Ozzie10aaaa (talk) 17:36, 18 April 2024 (UTC)[reply]

Your submission at Articles for creation: Pimicotinib has been accepted

Pimicotinib, which you submitted to Articles for creation, has been created.

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions.

The article has been assessed as Start-Class, which is recorded on its talk page. Most new articles start out as Stub-Class or Start-Class and then attain higher grades as they develop over time. You may like to take a look at the grading scheme to see how you can improve the article.

Since you have made at least 10 edits over more than four days, you can now create articles yourself without posting a request. However, you may continue submitting work to Articles for creation if you prefer.

If you have any questions, you are welcome to ask at the help desk. Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.

If you would like to help us improve this process, please consider leaving us some feedback.

Thanks again, and happy editing!

Ozzie10aaaa (talk) 17:37, 18 April 2024 (UTC)[reply]